Further validation of the association between <i>MAPT</i> haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and <i>APOE</i> genotype. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.